EX-23.4 7 fs82020ex23-4_aytubio.htm CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS OF THE ABBREVIATED FINANCIAL STATEMENTS OF THE PEDIATRICS PRODUCT PORTFOLIO OF CERECOR, INC

Exhibit 23.4

Consent of Independent Auditors

We consent to the incorporation by reference in the Registration Statements (Form S-8) pertaining to the 2015 Stock Option and Incentive Plan, as amended, of Aytu Bioscience, Inc. of our report dated January 3, 2020, with respect to the abbreviated financial statements of the Pediatrics Product Portfolio of Cerecor Inc. as of September 30, 2019 and December 31, 2018 and for the nine months ended September 30, 2019 and for the year ended December 31, 2018, included in Aytu Bioscience, Inc. Form 8-K/A filed with the Securities and Exchange Commission on January 10, 2020.

/s/ Ernst & Young LLP

Baltimore, Maryland

February 24, 2020